Expertise in
8
conditions

Dr. Craig Zaidman

Neurology
Washington University
660 S Euclid Ave, 
Saint Louis, MO 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
8
conditions
Washington University
660 S Euclid Ave, 
Saint Louis, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Craig Zaidman is a Neurologist in Saint Louis, Missouri. Dr. Zaidman is highly rated in 8 conditions, according to our data. His top areas of expertise are Becker Muscular Dystrophy, Duchenne Muscular Dystrophy, Spinal Muscular Atrophy (SMA), and Primary Lateral Sclerosis.

His clinical research consists of co-authoring 78 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Neurology with Special Qualifications in Neurology in MO
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

Washington University
660 S Euclid Ave, Saint Louis, MO 63110
Call: 314-362-6981
Other Locations
Office
1 Childrens Pl Ste 2D, Saint Louis,, MO 63110
Call: 314-454-6120

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Open Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies
Open Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies
Enrollment Status: Recruiting
Publish Date: January 21, 2026
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants With Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy With Multiple Copies of SMN2
A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants With Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy With Multiple Copies of SMN2
Enrollment Status: Completed
Publish Date: January 26, 2026
Intervention Type: Biological
Study Drug: Onasemnogene Abeparvovec-Xioi
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study With an Open-Label Extension to Determine the Safety, Pharmacokinetics and Efficacy of Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study With an Open-Label Extension to Determine the Safety, Pharmacokinetics and Efficacy of Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
Enrollment Status: Active_not_recruiting
Publish Date: January 26, 2026
Intervention Type: Drug
Study Drug: Ifetroban
Study Phase: Phase 2
Phase I, Open-Label, Dose Comparison Study of AVXS-101 for Sitting But Non-ambulatory Patients With Spinal Muscular Atrophy
Phase I, Open-Label, Dose Comparison Study of AVXS-101 for Sitting But Non-ambulatory Patients With Spinal Muscular Atrophy
Enrollment Status: Terminated
Publish Date: January 26, 2026
Intervention Type: Biological
Study Phase: Phase 1
A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects With Duchenne Muscular Dystrophy (EMBARK)
A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects With Duchenne Muscular Dystrophy (EMBARK)
Enrollment Status: Completed
Publish Date: July 08, 2025
Intervention Type: Genetic
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Terminated
Publish Date: August 26, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Subjects With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
A Phase 3, Randomized, Double-Blind Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Subjects With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Terminated
Publish Date: March 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: February 02, 2023
Intervention Type: Drug
Study Drug: Givinostat
Study Phase: Phase 3
View 7 Less Clinical Trials

77 Total Publications

Consensus recommendations and considerations for the delivery and monitoring of gene therapy in patients with Duchenne muscular dystrophy.
Consensus recommendations and considerations for the delivery and monitoring of gene therapy in patients with Duchenne muscular dystrophy.
Journal: Neuromuscular disorders : NMD
Published: June 17, 2025
View All 77 Publications
Similar Doctors
Expertise in
15
conditions
Dr. David Gutmann
Neurology
Expertise in
15
conditions
Dr. David Gutmann
Neurology
1 Childrens Pl, Div Neurology Pediatrics, 
Saint Louis, MO 
 (0.3 miles away)
314-362-1408
Languages Spoken:
English
See accepted insurances

David Gutmann is a Neurologist in Saint Louis, Missouri. Dr. Gutmann is highly rated in 15 conditions, according to our data. His top areas of expertise are Neurofibromatosis, Optic Glioma, Neurofibromatosis Type 1 (NF1), and Glioma.

David M. Holtzman
Expertise in
13
conditions
Dr. David M. Holtzman
Neurology
Expertise in
13
conditions
Dr. David M. Holtzman
Neurology

Washington University

4455 Duncan Ave, 
Saint Louis, MO 
 (0.1 miles away)
314-362-1408
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Holtzman is a Neurologist in Saint Louis, Missouri. Dr. Holtzman is highly rated in 13 conditions, according to our data. His top areas of expertise are Alzheimer's Disease, Dementia, Primary Amyloidosis, Cerebral Amyloid Angiopathy, and Gastrostomy. Dr. Holtzman is currently accepting new patients.

Randall J. Bateman
Expertise in
15
conditions
Dr. Randall J. Bateman
Neurology
Expertise in
15
conditions
Dr. Randall J. Bateman
Neurology

Washington University

4455 Duncan Ave, 
Saint Louis, MO 
 (0.1 miles away)
314-362-1408
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Randall Bateman is a Neurologist in Saint Louis, Missouri. Dr. Bateman is highly rated in 15 conditions, according to our data. His top areas of expertise are Alzheimer's Disease, Dementia, Primary Amyloidosis, and Cerebral Amyloid Angiopathy. Dr. Bateman is currently accepting new patients.

VIEW MORE Neurologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zaidman's expertise for a condition
ConditionClose
  • Elite
  • Becker Muscular Dystrophy
    Dr. Zaidman is
    Elite
    . Learn about Becker Muscular Dystrophy.
    See more Becker Muscular Dystrophy experts
  • Duchenne Muscular Dystrophy
    Dr. Zaidman is
    Elite
    . Learn about Duchenne Muscular Dystrophy.
    See more Duchenne Muscular Dystrophy experts
  • Distinguished
  • Cramp-Fasciculation Syndrome
    Dr. Zaidman is
    Distinguished
    . Learn about Cramp-Fasciculation Syndrome.
    See more Cramp-Fasciculation Syndrome experts
  • Primary Lateral Sclerosis
    Dr. Zaidman is
    Distinguished
    . Learn about Primary Lateral Sclerosis.
    See more Primary Lateral Sclerosis experts
  • Spinal Muscular Atrophy (SMA)
    Dr. Zaidman is
    Distinguished
    . Learn about Spinal Muscular Atrophy (SMA).
    See more Spinal Muscular Atrophy (SMA) experts
  • Advanced
  • Mononeuritis Multiplex
    Dr. Zaidman is
    Advanced
    . Learn about Mononeuritis Multiplex.
    See more Mononeuritis Multiplex experts
  • Spinal Muscular Atrophy Type 2
    Dr. Zaidman is
    Advanced
    . Learn about Spinal Muscular Atrophy Type 2.
    See more Spinal Muscular Atrophy Type 2 experts
  • Spinal Muscular Atrophy Type 3
    Dr. Zaidman is
    Advanced
    . Learn about Spinal Muscular Atrophy Type 3.
    See more Spinal Muscular Atrophy Type 3 experts
  • Experienced
  • Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
    Dr. Zaidman is
    Experienced
    . Learn about Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).
    See more Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) experts
  • Brachial Plexopathy
    Dr. Zaidman is
    Experienced
    . Learn about Brachial Plexopathy.
    See more Brachial Plexopathy experts
  • Charcot-Marie-Tooth Disease
    Dr. Zaidman is
    Experienced
    . Learn about Charcot-Marie-Tooth Disease.
    See more Charcot-Marie-Tooth Disease experts
  • Chronic Demyelinizing Neuropathy with IgM Monoclonal
    Dr. Zaidman is
    Experienced
    . Learn about Chronic Demyelinizing Neuropathy with IgM Monoclonal.
    See more Chronic Demyelinizing Neuropathy with IgM Monoclonal experts
  • Chronic Inflammatory Demyelinating Polyneuropathy
    Dr. Zaidman is
    Experienced
    . Learn about Chronic Inflammatory Demyelinating Polyneuropathy.
    See more Chronic Inflammatory Demyelinating Polyneuropathy experts
  • Chronic Polyradiculoneuritis
    Dr. Zaidman is
    Experienced
    . Learn about Chronic Polyradiculoneuritis.
    See more Chronic Polyradiculoneuritis experts
View All 24 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
  1. Homepage
  2. Neurologists Saint Louis, MO
  3. Dr. Craig Zaidman
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    Once you submit your request, MediFind will reach out to the provider’s office to help schedule your appointment. Note that this is not a confirmed booking. You’ll receive a status update via email within 1–2 business days.

    Patient Details

    This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.